Pfizer (NYSE:PFE) is preparing to release its quarterly earnings on Tuesday, 2025-11-04. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Pfizer to report an earnings per share (EPS) of $0.65.
The market awaits Pfizer's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
The company's EPS beat by $0.20 in the last quarter, leading to a 3.31% drop in the share price on the following day.
Here's a look at Pfizer's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.58 | 0.67 | 0.46 | 0.62 |
| EPS Actual | 0.78 | 0.92 | 0.63 | 1.06 |
| Price Change % | -3.00 | 3.00 | 2.00 | 0.00 |
Stock Performance
Shares of Pfizer were trading at $24.65 as of October 31. Over the last 52-week period, shares are down 11.93%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Pfizer visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
